What paid social creative works for D2C health brands without breaking policy?

Every health ad faces two reviewers. The platform's ad review checks it against its own health and personal-attribute policies, and the FTC can later judge whether the claims are truthful and substantiated. Creative fails when it promises outcomes the brand cannot prove, singles out a viewer's health condition, or uses visuals that imply medical results.

Platform rules change often and differ by product type, so this guide stays at a high level: check the platform's current policy before each campaign. The legal side is steadier. The FTC Health Products Compliance Guidance (December 2022) says health claims need competent and reliable scientific evidence, generally randomized controlled trials in humans. It also judges an ad by the net impression reasonable consumers take away from the whole thing, including text, images and the product name.

The usual reasons creative fails

• Outcome promises: specific results, timelines or guarantees the brand cannot substantiate.
• Personal-attribute hooks: lines like "Struggling with your weight?" that assert or imply the viewer has a health condition. Several platforms restrict this.
• Disease implications: any suggestion that a supplement treats, cures or prevents a disease.
• Misleading visuals: dramatic before-and-after images, lab coats implying medical endorsement, or charts without a source.
• Offer mismatches: "free" in the ad and a recurring charge on the checkout page.

Our explainer on Meta and Google ad policies for supplements covers the platform side in more detail.

Passing ad review is not the same as being lawful

An ad that the platform approves can still be deceptive under the FTC Act, and an ad the platform rejects may be perfectly lawful. Automated review looks for patterns, such as health words, body imagery or sensitive targeting. The FTC looks at what the claim means and whether you can prove it. Build creative to satisfy the stricter standard on each point: the platform's rules on targeting and imagery, and the FTC's rules on truth and evidence.

Yes. Under FTC guidance the net impression of an ad includes its images, and FDA's structure/function rule lists pictures, vignettes and symbols among the ways a supplement can imply a disease claim. A heart graphic, a hospital bed or a blood-sugar meter in a supplement ad can say more than the caption does.

FDA's rule at 21 CFR 101.93(g) describes when a statement on supplement labeling is a disease claim. Among the listed factors are the product name and the use of pictures, vignettes, symbols or other means. Ads are the FTC's territory, but the same visual logic applies when regulators read the overall message.

A visual checklist for every asset

• No medical devices, test results or diagnostic imagery next to the product.
• No anatomical overlays that point to a diseased organ.
• No lab coats or clinical settings unless the person is a real, disclosed professional and the claim is substantiated.
• No charts or percentages without a cited source on screen.
• On-screen text checked with the same claim rules as captions.
• Product name and packaging in shot match approved labeling.

Video adds a timing issue. A disclaimer that flashes for a moment in small type is unlikely to count as clear and conspicuous. If a qualification is needed to keep a claim truthful, put it on screen long enough to read and say it in the audio as well. Better still, choose a claim that needs no qualification.

Product names and packaging in shot

FDA lists the product name itself as a factor that can imply a disease claim. If a product name or a variant name hints at a disease, every ad that shows the pack repeats that implication. Fix naming problems at the label stage, before creative is built around them. The same goes for bundle names and discount codes, which viewers read as part of the message.

If an ad leads to a recurring charge, the Restore Online Shoppers' Confidence Act (ROSCA) applies to the online sale. The seller must clearly disclose the material terms before taking billing information, get the buyer's express informed consent before charging, and provide a simple way to stop recurring charges. The ad and landing page must not contradict that.

The FTC's business guidance on ROSCA violations describes a checkout where the trial terms sat in small grey fine print and behind an obscure "terms and conditions" link, a pattern it treated as a ROSCA problem. In ad creative, that means a few practical rules.

• Do not say "free" if the offer converts to a paid subscription unless the terms are clear where the buyer commits.
• Show the recurring nature of a subscribe-and-save offer plainly, not only in a footnote.
• Keep the price, frequency and cancellation route consistent across the ad, landing page and checkout.
• Test cancellation yourself; if it is hard, fix it before you scale spend.

Discounts, guarantees and urgency

Offer creative carries its own truthfulness rules. A "limited time" banner should reflect a real end date. A crossed-out price should be a price you actually charged. A satisfaction guarantee should state its conditions in the ad or one click away, and the team handling refunds should honor it exactly as advertised. These details rarely trigger ad rejections, but they are a common source of customer complaints, chargebacks and regulator attention.

Subscriptions are often the economic engine of a D2C health brand, so getting this right protects the business as well as the ad account. Our guide to growing subscriptions with email and SMS covers retention after the first order. Confirm offer terms with counsel.

We write and test paid social creative for supplement and D2C health brands using a claims brief, a written review step and a rejection log, and we run campaigns on Meta, Instagram, TikTok and YouTube. ICG has worked only in healthcare and health brands since 2018, across 150+ healthcare and life-sciences brands.

What a typical creative month includes

• A claims brief agreed with you and checked against your evidence file.
• A batch of new concepts across demonstration, routine, founder and creator formats.
• A pre-launch review of every script, caption and on-screen line.
• Small-budget tests, then scaled spend on the concepts that convert.
• A rejection and comment log, with fixes fed into the next brief.

Our work is Goals-Driven. Targets such as cost per new customer or subscription take rate are set with you monthly, visible live on Ichelon Agency OS, and reported every Monday. Pricing can follow a Performance-Linked Payout Model; retainers begin at $499/month and are scoped to your channels. Learn more on our supplement and D2C health brand marketing page or book a call with the US team.